Article

Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the…

Journal of Diabetes Research · 2015 · Ze-jun Ma, author Xiao-na Zhang, author Li Li, author Wei Yang, author Shan-shan Wang, author Xin Guo, author Pei Sun, author Li-ming Chen, author Jennifer L. Wilkinson-Berka, Academic Editor

Key facts

Title Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats
First author Ze-jun Ma, author Xiao-na Zhang, author Li Li, author Wei Yang, author Shan-shan Wang, author Xin Guo, author Pei Sun, author Li-ming Chen, author Jennifer L. Wilkinson-Berka, Academic Editor
Journal Journal of Diabetes Research
Published Apr 29, 2015
DOI 10.1155/2015/390428
Devices mentioned K011853, K040782, K833167, K833273, K851606, K870482, K892844, K922885, K925155, K990017, K990149, K990150 and 8 more
Product codes mentioned CDQ, CEK, CIT, DHR, ICN, JAK, JJX, JJY, KIP, KIT, LED

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature